European Medical Solutions (LTS:0RGO) Net Interest Margin (Bank Only) %


LTS:0RGO European Medical Solutions LTS:0RGO
43 GF Score
Price €4.70
GF Value €9.64
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0RGO
43GF Score
European Medical Solutions LTS:0RGO
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is European Medical Solutions (LTS:0RGO) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.70 is trading 51.2% below its estimated GF Value™ of €9.64.

Key valuation signals for LTS:0RGO:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €9.64 vs. price of €4.70 (51.2% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the LTS:0RGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
43GF Score

Get the complete analysis for LTS:0RGO

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.70
Price
€9.64
GF Value